X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    FDA Accepts BLA for Recommended

    FDA Accepts BLA for Recommended Biosimilar to Simponi

    Merck to Acquire Verona

    Merck to Acquire Verona Pharma in $10B Deal Boosts COPD Drug

    Emerging Oral Small Molecule Drugs

    Emerging Oral Small-Molecule Drugs for Ultra-Rare Diseases

    FDA Approves Oral Therapy for Treating Hereditary Angioedema

    FDA Approves Oral Therapy for Treating Hereditary Angioedema

    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    FDA Accepts BLA for Recommended

    FDA Accepts BLA for Recommended Biosimilar to Simponi

    Merck to Acquire Verona

    Merck to Acquire Verona Pharma in $10B Deal Boosts COPD Drug

    Emerging Oral Small Molecule Drugs

    Emerging Oral Small-Molecule Drugs for Ultra-Rare Diseases

    FDA Approves Oral Therapy for Treating Hereditary Angioedema

    FDA Approves Oral Therapy for Treating Hereditary Angioedema

    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Manufacturing

Medivant Launches Pharma Manufacturing operations in US

Content Team by Content Team
11th May 2020
in Manufacturing, News
Medivant Launches Pharma Manufacturing operations in US

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

A new U.S.-based pharmaceutical manufacturer, Tailstorm Health, Inc., DBA Medivant Healthcare, will begin to roll out sterile single dose liquid injectable medications on the FDA’s Drug Shortage List. Medivant’s initial products will include sterile liquid injectables that are in dire need in the ICU for COVID-19 patients.

Throughout the country, hospitals have experienced difficulties receiving orders for more than a dozen sedatives, anesthetics, painkillers, and muscle relaxants, which have been in short supply. Recent reports have shown that orders for these medications are only being filled and shipped to hospitals 53% of the time. Medivant Healthcare said it will quickly fill the needed void and supply hospitals with safe, sterile medications.

Based in Chandler, AZ, Medivant Healthcare is a boutique, cGMP (Current Good Manufacturing Practice) compliant manufacturer, guided by automation that naturally leads to greater output.

Capable of producing 80,000 vials of 1-10 ML single dose liquid injectables per day, Medivant’s facility averages 40,000 vials per shift with a staff of roughly 25 fully-trained professionals. Rollout over the coming year is expected to reach nearly half of the U.S. and their current count of 16 molecules in production will reach 25 plus by 2021.

Medivant Healthcare counts on extensive lineage in the larger pharmaceutical manufacturing world, managed by ownership that dates three generations in pharmaceuticals.

“Over the long-term, Medivant seeks to be a leader in this niche area of hospital drug shortages,” said Viraj Gandhi, owner and director, Medivant. “We are hoping to revive pharmaceutical manufacturing interest in the U.S.”

Medivant serves hospitals, hospital groups, surgical centers, doctors’ offices and emergency centers. It is a business-to-business model with no direct to consumer sales.

Andrew Stasiak, director of quality control, Medivant, said, “As a cGMP manufacturer, safety and quality are paramount and guide all decisions across the organization. Automation has led to little to no human error, and our in-house specialist QA teams work diligently to ensure compliance is met no matter how minute or seemingly insignificant the detail.”

Medivant will immediately begin distributing the following medications to hospital and emergency rooms throughout the U.S.: Lidocane (local anesthetic), Bupivacine (local anesthetic), Ketorolac (non-opioid pain management, Diltiazem (heart medication), Ondansetron (nausea medication), Tramadol (non-opioid pain management), Calcium Chloride (heart medication), Ketamine (C3 pain management, based on licensing approval by DEA), Dextrose (low blood sugar), Metoprofol (heart medication), Ibuprofen (non-opioid pain management), Midazolam (C4 sedative, based on licensing approval by DEA).

Previous Post

Pfizer and BioNTech Dose First Participants in the U.S. as Part of Global COVID-19 mRNA Vaccine Development Program

Next Post

Aptar Submits Application for EUA to the German Regulatory Agency BfArM for ActivShieldTM FFP2 Decontamination System

Related Posts

FDA Accepts BLA for Recommended
FDA Approvals

FDA Accepts BLA for Recommended Biosimilar to Simponi

22nd July 2025
Merck to Acquire Verona
Drug Development

Merck to Acquire Verona Pharma in $10B Deal Boosts COPD Drug

21st July 2025
ChiRhoClin LogiCare3PL Partners for Drug Distribution
News

ChiRhoClin, LogiCare3PL Partners for Drug Distribution

21st July 2025
Thermo Fisher and Sanofi Partners
Manufacturing

Thermo Fisher and Sanofi Partners for US Drug Manufacturing

21st July 2025
EMA Recommendations to Secure Anti D Immunoglobulins Supply
News

EMA Recommendations to Secure Anti-D Immunoglobulins Supply

15th July 2025
FDA Approves Oral Therapy for Treating Hereditary Angioedema
FDA Approvals

FDA Approves Oral Therapy for Treating Hereditary Angioedema

15th July 2025
Next Post
Aptar Submits Application for EUA  to the German Regulatory Agency BfArM for ActivShieldTM FFP2 Decontamination System

Aptar Submits Application for EUA to the German Regulatory Agency BfArM for ActivShieldTM FFP2 Decontamination System

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In